Nykode Company
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops novel vaccines against HPV-induced malignacies
Technology:
Bioengineering
Industry:
Public, Tumor-Specific Antigens
Headquarters:
Oslo, Oslo, Norway
Founded Date:
2007-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
2
Total Funding:
31733000
Estimated Revenue:
Less than $1M
Last Funding Date:
2016-12-16
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership